Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRN | P28799 | 1/20 | 0.56 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.56 |
| ▸ | KLKB1 | P03952 | 5/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CARM1 | Q86X55 | 6/20 | 0.48 |
| ▸ | KCNJ6 | P48051 | 1/20 | 0.48 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.48 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.48 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL950904 | 0.88 | GRN (0.72) | GRNSORT1KLKB1PTGS1KDM4E | |
| SCHEMBL27584609 | 0.85 | KLKB1 (0.61) | GRNSORT1KLKB1PTGS1KDM4E | |
| SCHEMBL6173027 | 0.82 | PTGS2 (0.60) | PTGS1PTGS2 | |
| SCHEMBL7231373 | 0.82 | KLKB1 (0.51) | KLKB1CARM1 | |
| SCHEMBL951285 | 0.81 | RXRA (0.49) | KLKB1PTGS1KDM4EALDH1A1CARM1 | |
| SCHEMBL1670472 | 0.81 | GRN (0.56) | GRNSORT1KLKB1PTGS1KDM4E | |
| SCHEMBL12361486 | 0.80 | KLKB1 (0.75) | KLKB1CARM1MAPT | |
| SCHEMBL5584120 | 0.78 | KLKB1 (0.69) | GRNSORT1KLKB1KDM4E | |
| SCHEMBL12361464 | 0.78 | ALDH1A1 (0.53) | GRNSORT1KLKB1PTGS1KDM4E | |
| SCHEMBL18604629 | 0.78 | PTGS2 (0.58) | GRNSORT1KLKB1PTGS1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9173400-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-8697734-B2 | Method for controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-04-15 | — | — | US | disclosed |
| US-8637552-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| US-7998995-B2 | LXR and FXR modulators | EXELIXIS PATENT COMPANY LLC (US) | 2011-08-16 | — | — | US | disclosed |
| US-20100160307-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-04-07 | — | — | US | disclosed |
| CN-1541063-A | Method for controlling particular insects by applying anthranilamide compounds | ��Ļ���Ű˾ | 2004-10-27 | — | — | CN | disclosed |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | FMC CORPORATION | 2004-10-21 | — | — | US | disclosed |
| US-20040142984-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2004-07-22 | — | — | US | disclosed |
| EP-1427285-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. du Pont de Nemours and Company (US) | 2004-06-16 | — | — | EP | disclosed |
| US-6747047-B2 | ARTHROPODICIDES | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-08 | — | — | US | disclosed |
| EP-1416796-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030229050-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2003-12-11 | — | — | US | disclosed |
| WO-2003024222-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-03-27 | — | — | WO | disclosed |
| WO-2003015518-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160307-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, HRH4, HDAC10 | GRN 3481/4885SORT1 3126/4885KLKB1 3840/4885 |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | ANTXR2, NIT2, TDO2 | GRN 3252/4885SORT1 2640/4885KLKB1 3874/4885 |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | GRN 2806/4885SORT1 1386/4885KLKB1 4489/4885 |
| US-20040142984-A1 | Insecticidal anthranilamides | ANTXR2, NIT2, AKR7A2 | GRN 4628/4885SORT1 4688/4885KLKB1 3650/4885 |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | ANTXR2, ARF5, NPM1 | GRN 2638/4885SORT1 1794/4885KLKB1 4175/4885 |
| US-20030229050-A1 | Insecticidal anthranilamides | ANTXR2, NIT2, CYB5R3 | GRN 4664/4885SORT1 4741/4885KLKB1 3480/4885 |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, CYP4X1, PRDX1 | GRN 4350/4885SORT1 3540/4885KLKB1 3929/4885 |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | ANTXR2, HRH4, HDAC10 | GRN 3403/4885SORT1 3118/4885KLKB1 3842/4885 |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | GRN 2806/4885SORT1 1386/4885KLKB1 4489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.